IDO-triggered swellable polymeric micelles for IDO inhibition and targeted cancer immunotherapy
Journal of Controlled Release · 2023
DOI: 10.1016/j.jconrel.2023.09.050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023. Verfasst von Jaehyun Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, South Korea. Electron…. Hauptthemen laut MEDLINE: Tryptophan, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Ministry of Science, ICT and Future Planning, National Research Foundation of Korea.
Abstract (Originalsprache)
Indoleamine 2,3-dioxygenase (IDO) has been studied as a promising target for cancer immunotherapy. IDO catalyzes the oxidation of tryptophan into kynurenine, which subsequently activates regulatory T cells, thereby promoting an immunosuppressive microenvironment in the tumor tissue. Due to its overexpression in tumor cells, IDO itself could be a tumor-specific stimulus for targeted cancer therapy. Toward this objective, we developed IDO-triggered swellable micelles for targeted cancer immunotherapy. The micelles are prepared by the self-assembly of amphiphilic polymers containing polymerized tryptophan as a hydrophobic block. The micelles exhibited IDO-responsive behavior via solubility conversion of the hydrophobic core triggered by the oxidation of tryptophan residues into kynurenine. The micelles were internalized into tumor cells and disassembled by overexpressed IDO. Loaded with IDO inhibitor, the micelle presented enhanced therapeutic antitumor effect, and effector T-cells were recruited into the tumor tissue. We demonstrated that overexpressed IDO in cancer cells could be utilized as a tumor-specific stimulus, and utilizing an IDO-responsive drug delivery system holds great promise for targeted cancer therapy and immunomodulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, South Korea. Electronic address: jhpark16@postech.ac.kr.
- Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, POSTECH, Pohang 37673, South Korea. Electronic address: nahyy48@postech.ac.kr.
- School of Interdisciplinary Bioscience and Bioengineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, South Korea; Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, PO…
Förderung
- Ministry of Science, ICT and Future Planning
- National Research Foundation of Korea
Zitieren
APA
Park, J., Nah, Y., & Kim, W. J. (2023). IDO-triggered swellable polymeric micelles for IDO inhibition and targeted cancer immunotherapy. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2023.09.050
Vancouver
Park J, Nah Y, Kim WJ. IDO-triggered swellable polymeric micelles for IDO inhibition and targeted cancer immunotherapy. Journal of Controlled Release. 2023. doi:10.1016/j.jconrel.2023.09.050
BibTeX
@article{Park2023,
author = {Park, Jaehyun and Nah, Yunyoung and Kim, Won Jong},
title = {IDO-triggered swellable polymeric micelles for IDO inhibition and targeted cancer immunotherapy},
journal = {Journal of Controlled Release},
year = {2023},
doi = {10.1016/j.jconrel.2023.09.050}
}
EUVIMED